SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Hamlin who wrote (985)11/9/1998 10:32:00 PM
From: Wisee  Read Replies (1) | Respond to of 1185
 
Kevin,

It seems most of the biotech stocks on the VSE were up:

NRT $1.30 +.12
FMI $9.00 +.95
IZP $ .65 +.11
IGT $ .63 +.03

It seems that these stocks have bottomed.

Maybe this sector is back in favour with analysts & investors.

Wisee



To: Kevin Hamlin who wrote (985)11/10/1998 1:13:00 AM
From: Intrepid1  Read Replies (1) | Respond to of 1185
 
Hi Kevin, a few months back Golden Capital (House 38 0n the VSE) wrote a very bullish research report on Nortran. Glad to see they are still active.

Mind you, I am still a little sore at Golden Capital because they complained to S.I. when I posted it on this thread. <g>

purething


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News